Chindex International Announces Financing Program With the International Finance Corporation of the World Bank Group 10 Year Program To Fund Continued Hospital Network Growth

Beijing, China, October 12, 2005 - Chindex International, Inc. (NASDAQ:CHDX) announced today the finalization of a long-term financing program with the International Finance Corporation, the private sector arm of the World Bank Group. The IFC has provided an RMB 64.88 million loan to support Chindex International's United Family Hospitals and Clinics (UFH), a leading Chinese hospital group with facilities in Beijing and Shanghai .

The IFC funds will be used for medical equipment and facilities upgrades at the UFH network's newly opened Shanghai hospital, its flagship hospital in Beijing , an outpatient clinic in downtown Beijing and to launch a medical training program to teach the latest in international standard patient care to nurses from both the public and private sector. The funds will also partially be used for retiring other debt currently held by the facilities resulting in a more traditional balance sheet structure for a developing hospital group.

The UFH network was established in 1997 to bring an unprecedented level of private healthcare services to mainland China . The group has introduced an international-standard model of patient-centered healthcare management and service. Its two general hospitals, similar to a Western "community" or "family" hospital, offer a wide range of medical and surgical inpatient services, outpatient consultations, ER and primary care in a beautiful and comforting environment. They are organized as separate legal entities. Each is a foreign-Sino joint venture majority owned directly by Chindex International, Inc.

Roberta Lipson, CEO of Chindex International, Inc. and Chairman of the Board of Directors of United Family Hospitals, said, "We are honored to partner with IFC in long term development programs for our hospital network. We believe that our United Family Hospital model provides leading edge patient services and the finest hospital management services available in China today. Our educational programs in nursing and other areas of care delivery have been recognized for their excellence. With IFC's help to provide financing for our continuing expansion of services and facilities we see continued growth of the hospital network."

"IFC's support of this hospital group is part of our ongoing effort to help private companies expand the access to international standards of high level, patient-centered health care services in China ," said IFC Director of Health and Education, Guy Ellena. "We expect United Family Hospitals to continue programs that have established new benchmarks of medical excellence and outstanding quality of patient care in China ."

Bart Daniel, Vice President for Finance and CFO of United Family Hospitals also noted, "The IFC financing gives us the opportunity to continue investment in expansion of our services in both the Beijing and Shanghai markets. We will also take advantage of the long-term nature of the program to restructure our existing debt."

"IFC's investment in United Family Hospitals shows our commitment to social sector development in China ," said IFC's Director for East Asia and the Pacific, Javed Hamid. "By providing long-term, local currency financing we are helping to develop a market for the financing of health care facilities, which tend to be long term, capital-intensive efforts with revenues in the local currency."

Since 1985, IFC has invested more than $2 billion in 100 private sector companies in China. The International Finance Corporation, the private sector arm of the World Bank Group, promotes sustainable private sector investment in developing and transition countries, helping to reduce poverty and improve people's lives. IFC finances private sector investments, mobilizes capital in the international financial markets, helps clients improve social and environmental sustainability, and provides technical assistance and advice to governments and businesses. Its 178 member countries provide its share capital and collectively determine its policies. From its founding in 1956 through FY05, IFC has committed more than $49 billion of its own funds and arranged $24 billion in syndications for 3,319 companies in 140 developing countries. IFC's worldwide committed portfolio as of FY05 was $19.3 billion for its own account and $5.3 billion held for participants in loan syndications. For more information, visit www.ifc.org .

Chindex International Inc. is an American company operating in several healthcare sectors of the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Hospital network of private hospitals operating in the Beijing and Shanghai. It also provides representative and distribution services to a number of major multinational companies including Siemens AG (ultrasound systems) and Guidant (interventional cardiology products including stents, balloon catheters and guide wires). Its distribution channels to the retail pharmacy industry in China have been developed through a relationship with a major multinational cosmetics manufacturer. With twenty-four years of experience, over 1,000 employees, and operations in the United States, China and Hong Kong, the Company's strategy is to expand its cross-cultural reach by providing leading edge technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, www.chindex.com and www.unitedfamilyhospitals.com .

Some of the information in this release may contain statements regarding future expectations, plans, prospects for performance of the Company that constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. The Company cannot guarantee future results, levels of activity, performance or achievements. The numbers discussed in this release also involve risks and uncertainties. The following factors, among others, could cause actual results to differ materially from those described by such statements: our ability to manage our growth and maintain adequate controls, our ability to obtain additional financing, the loss of services of key personnel, general market conditions including inflation or foreign currency fluctuations, our dependence on relationships with suppliers, the timing of our revenues and fluctuations in financial performance, the availability to our customers of third-party financings, product liability claims and product recalls, competition, hiring and retaining qualified sales and service personnel, management of inventory, relations with foreign trade corporations, dependence on sub-distributors and dealers, completion and opening of healthcare facilities, attracting and retaining qualified physicians and other hospital personnel, regulatory compliance, the cost of malpractice, our dependence on our information systems, the economic policies of the Chinese government, the newness and undeveloped nature of the Chinese legal system, the regulation of the conversion of Chinese currency, future epidemics in China such as SARS, the control over our operation by insiders, continuity of relationships and variability of financial margins with existing suppliers, our liquidity and availability of capital resources to meet cash requirements, including capital expenditures and those other factors contained in the section titled "Risk Factors" as set forth on page 6 of the Company's Registration Statement on Form S-3 (File No. 333-123975) declared effective by the Securities and Exchange Commission on April 20, 2005, as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. The forward-looking statements and numbers contained herein represent the judgment of the Company, as of the date of this press release, and the Company disclaims any intent or obligation to update such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions, circumstances on which such statements are based.